As more patents make their way through IPRs, the balance of how the pharmaceutical industry selects between IPRs and district court litigation will likely evolve.
Erica Pascal
Advertisement
Dr. Erica Pascal is a partner in DLA Piper’s Patent Litigation practice
Articles by Erica Pascal
Advertisement
Latest Updated Articles
- Are IPRs Impacting the Pharmaceutical Industry?
July 24th 2015
Advertisement
Advertisement